Key terms

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CLNN news

Yesterday 6:20am ET Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB) by TipRanks Apr 16 4:24pm ET Clene Announces Breakthrough MS Therapy at Neurology Meeting by TipRanks Apr 16 4:22pm ET Clene presents VISIONARY-MS long term extension study results by TipRanks Mar 20 7:21am ET Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Clene (CLNN) and Jazz Pharmaceuticals (JAZZ) by TipRanks Mar 15 1:45pm ET Buy Rating Affirmed for Clene Amid Positive ALS Drug Data and Market Dynamics by TipRanks Mar 15 8:20am ET Clene announces peer-reviewed publication on CNM-Au8 by TipRanks Mar 13 8:09am ET Clene expects cash to fund operations into 4Q24 by TipRanks Mar 13 8:09am ET Clene reports 2023 EPS (47c), consensus (45c) by TipRanks Mar 11 8:40am ET Analysts Offer Insights on Healthcare Companies: Clene (CLNN), REPRO-MED Systems (KRMD) and Bioventus (BVS) by TipRanks Feb 29 10:25am ET Buy Rating Affirmed for Clene’s CNM-Au8 on Promising Long-Term Clinical Outcomes by TipRanks Feb 29 8:23am ET Clene Announces Breakthrough CNM-Au8 Treatment Results by TipRanks Feb 29 8:16am ET Clene presents clinical results of CNM-Au8 30mg treatment by TipRanks Feb 22 11:37am ET Buy Rating Affirmed for Clene Amidst Strong Clinical Data and Financial Stability by TipRanks Feb 22 8:12am ET Clene’s CNM-Au8 Shows Promise in ALS Survival Rates by TipRanks Feb 22 8:07am ET Clene reports ‘significant’ survival results from two analyses of CNM-Au8 by TipRanks

No recent press releases are available for CLNN

CLNN Financials

1-year income & revenue

Key terms

CLNN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CLNN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming